Recent Blog Articles

Harvard Health Blog

Meningitis vaccines: What parents need to know

Published: August 08, 2018
  • Author: Claire McCarthy, MD,


As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.


vinu arumugham
August 26, 2018

Before the introduction of the Menactra and Menveo vaccines in 2005 and 2010 respectively, incidence rate of meningococcal disease in the US was ~1 in 100,000.

The Menveo package insert

“Among subjects with symptom onset within 42 days of vaccination (days 12, 25, 29), 3/12049 [0.02%, 95% CI: (0.01% ,0.07%)] MENVEO recipients and 0/2877 [0%, 95% CI: (0%, 0.13%)] control recipients were diagnosed with Kawasaki Disease.”

This article explains why Kawasaki disease occurs following Menveo.

SIDS, Kawasaki Disease and narcolepsy: Same mechanism, different vaccines.

So we are trading a 1 in 100,000 meningococcal disease rate for a 1 in 4000 Kawasaki disease rate?

Commenting has been closed for this post.